Evidence map›Paper›PMID 30264879›Full record

ArticleXenotransplantation2018

Pathogen elimination and prevention within a regulated, Designated Pathogen Free, closed pig herd for long-term breeding and production of xenotransplantation materials.

Jeske Noordergraaf, Adrienne Schucker, Mike Martin, Henk-Jan Schuurman, Brianne Ordway, Kevin Cooley, Marie Sheffler, Kara Theis, Chasa Armstrong, Laura Klein and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Xenotransplantation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 42 citations in OpenAlex.

  1. Genetically engineered porcine liver: a new era in transplantation.International journal of surgery (London, England) · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Potential Infectious Complications in Pig Xenograft Donors and Recipients.Transplant international : official journal of the European Society for Organ Transplantation · 2024
    Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Jeske NoordergraafSpring Point Project, Minneapolis, MN, USA.
Adrienne SchuckerSpring Point Project, Minneapolis, MN, USA.
Mike MartinSpring Point Project, Minneapolis, MN, USA.
Henk-Jan SchuurmanSchuBiomed Consultancy, Utrecht, the Netherlands.
Brianne OrdwaySpring Point Project, Minneapolis, MN, USA.
Kevin CooleySpring Point Project, Minneapolis, MN, USA.
Marie ShefflerSpring Point Project, Minneapolis, MN, USA.
Kara TheisSpring Point Project, Minneapolis, MN, USA.
Chasa ArmstrongSpring Point Project, Minneapolis, MN, USA.
Laura KleinSpring Point Project, Minneapolis, MN, USA.
Doug HansenSpring Point Project, Minneapolis, MN, USA.
Megan OlsonSpring Point Project, Minneapolis, MN, USA.
Lisa SchlechterSpring Point Project, Minneapolis, MN, USA.
Tom SpizzoSpring Point Project, Minneapolis, MN, USA.ORCID 0000-0001-8278-2461
Center Point · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe established a Source Animal (barrier) Facility (SAF) for generating designated pathogen-free (DPF) pigs to serve as donors of viable organs, tissues, or cells for xenotransplantation into clinical patients. This facility was populated with caesarian derived, colostrum deprived (CDCD) piglets, from sows of conventional-specific (or specified) pathogen-free (SPF) health status in six cohorts over a 10-month period. In all cases, CDCD piglets fulfilled DPF status including negativity for porcine circovirus (PCV), a particularly environmentally robust and difficult to inactivate virus which at the time of SAF population was epidemic in the US commercial swine production industry. Two outbreaks of PCV infection were subsequently detected during sentinel testing. The first occurred several weeks after PCV-negative animals were moved under quarantine from the nursery into an animal holding room. The apparent origin of PCV was newly installed stainless steel penning, which was not sufficiently degreased thereby protecting viral particles from disinfection. The second outbreak was apparently transmitted via employee activities in the Caesarian-section suite adjacent to the barrier facility. In both cases, PCV was contained in the animal holding room where it was diagnosed making a complete facility depopulation-repopulation unnecessary.

methodInfectious PCV was eliminated during both outbreaks by the following: euthanizing infected animals, disposing of all removable items from the affected animal holding room, extensive cleaning with detergents and degreasing agents, sterilization of equipment and rooms with chlorine dioxide, vaporized hydrogen peroxide, and potassium peroxymonosulfate, and for the second outbreak also glutaraldehyde/quaternary ammonium. Impact on other barrier animals throughout the process was monitored by frequent PCV diagnostic testing.

resultAfter close monitoring for 6 months indicating PCV absence from all rooms and animals, herd animals were removed from quarantine status.

conclusionTen years after PCV clearance following the second outbreak, due to strict adherence to biosecurity protocols and based on ongoing sentinel diagnostic monitoring (currently monthly), the herd remains DPF including PCV negative.

Indexed as

Specific Pathogen-Free OrganismsTransplantation, HeterologousAnimalsCircoviridae InfectionsCircovirusHeterograftsSwineSwine Diseasesdesignated pathogen free herdDPFporcine circovirussource animal facilityswinexenotransplantation

Identifiers

PMID30264879
PMCPMC7169735
OpenAlexW2886623857

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.